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Abstract: 
Objective: Prescription drug diversion, the transfer of prescription drugs from lawful to unlawful 
channels for distribution or use, is a problem in the United States. Despite the pervasiveness of diversion, 
there are gaps in the literature regarding characteristics of individuals who participate in the illicit trade 
of prescription drugs. This study examines a range of predictors (e.g., demographics, prescription 
insurance coverage, perceived risk associated with prescription drug diversion) of membership in three 
distinct diverter groups: individuals who illicitly acquire prescription drugs, those who redistribute them, 
and those who engage in both behaviors. Methods: Data were drawn from a cross-sectional Internet 
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study (N = 846) of prescription drug use and diversion patterns in New York City, South Florida, and 
Washington, D.C.. Participants were classified into diversion categories based on their self-reported 
involvement in the trade of prescription drugs. Group differences in background characteristics of 
diverter groups were assessed by Chi-Square tests and followed up with multivariate logistic regressions. 
Results: While individuals in all diversion groups were more likely to be younger and have a licit 
prescription for any of the assessed drugs in the past year than those who did not divert, individuals who 
both acquire and redistribute are more likely to live in New York City, not have prescription insurance 
coverage, and perceive fewer legal risks of prescription drug diversion. Conclusion: Findings suggest 
that predictive characteristics vary according to diverter group. 
  
Keywords: prescription drugs; diversion; illicit behavior; Internet-based study; United States 
 
1. Introduction  
The nonmedical use of prescription drugs, use not intended by a prescribing physician [1], has been 
well documented in the United States [2–6]. There are as many as 6.8 million current nonmedical users 
of psychotherapeutic drugs (e.g., pain medications, stimulants, depressants) in the country; of those, 4.9 
million use pain medications and 1.2 million use stimulants [7]. A potentially related problem of 
nonmedical prescription drug use is prescription drug abuse, which has increased markedly in recent 
years [1,8–11]. Between 1998 and 2008, the incidence of prescription drug abuse increased by 
400% [12]. Among young people, for instance, prescription drugs are the second most-abused 
category of drugs after marijuana [13]. As such, prescription drug abuse is the nation’s fastest-growing 
drug problem [14].  
Most experts consider prescription drug diversion to be a major driver of the country’s prescription 
drug abuse epidemic [15]. “Diversion” is the transfer of prescription drugs from lawful to unlawful 
channels for distribution or use [16]. Diversion entails the illicit acquisition of drugs from medical 
sources, primarily through theft [17,18], prescription forgery [19,20], and “shopping” for lenient 
physicians or pharmacists [15,21,22]. It also entails the illicit acquisition of prescription drugs from 
nonmedical sources, usually through trading, stealing, borrowing, or purchasing from family and 
friends [23–28], street-level drug dealers or markets [16,21,29], and online pharmacies or 
websites [23,30,31]. In addition to acquisition, diversion includes the illicit redistribution of 
prescription drugs outside of a licit healthcare context [5,20,22,25,32–34]. As Inciardi and Cicero [35] 
noted, diversion — both acquisition and redistribution — can happen along all points in the prescription 
drug delivery process, from manufacturing site to wholesale distributor to physician’s office to 
pharmacy to patient.  
Recent research shows an increase in prescription drug diversion in the United States [5,10,35]. 
This is associated with a variety of issues, such as increased emergency room visits [5,36], overdose and 
overdose-related deaths [9,37–39], crime [10] [40], healthcare treatment and costs [5,19,41], and drug 
prevention and interception expenses [42]. Despite these concerns, diversion remains an understudied 
problem [11,15,16,35,43]. Most studies of prescription drug diversion focus on diversion behaviors 
among particular populations, especially college students [27,28,33,44–47] and pain patients [25,48,49], 
or the diversion of specific prescription drugs, mainly opioids [26,32,50–52] and 
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stimulants [24,28,53,54]. Research with broader samples on more diverse drug classes would add to 
literature on prescription drug diversion.  
Although illicit acquisition and redistribution of prescription drugs is a key contributor to 
prescription drug misuse [15,25], there is a paucity of research examining correlates of engaging in 
illicit prescription drug acquisition and redistribution. The few studies that have studied predictors of 
prescription drug sharing and redistribution find that younger individuals are more likely to engage in 
the diversion of prescription drugs, including both acquisition and redistribution [55,56]. Findings 
regarding gender are mixed; some studies find more diversion among women, including both acquisition 
and redistribution [56–59], while others report no gender differences in acquisition [60]. Race/ethnicity 
differences have also been observed; some studies find that White, non-Hispanic individuals are more 
likely to redistribute prescription drugs [56] while others report no race/ethnicity differences in 
acquisition and redistribution [61,62]. Furthermore, the influence of income and prescription drug 
coverage on diversion behaviors [23] and perceptions of risks of diversion are understudied. A more in-
depth understanding of correlates of diversion behaviors could elucidate pathways that contribute to 
misuse. Additionally, it is important to replicate results with new samples and recruitment methods, 
which could help clarify inconsistencies in previous findings. 
The present study addresses this gap in the extant literature by offering insights into correlates of 
illicit acquisition and redistribution. Although both acquisition and redistribution are part of the 
prescription drug trade, these behaviors serve different functions and may be associated with different 
predictors that have not been previously examined in the prescription drug diversion literature. Drawing 
on studies of the illicit drug trade, it is likely that predictors of acquisition and redistribution are 
overlapping but also differ [63,64]. The limited attention to heterogeneity of behaviors that comprise 
diversion could lead to erroneous assumptions about the characteristics of individuals involved in illicit 
diversion of prescription drugs. As described above, age, race/ethnicity, and gender differences [56–59] 
have been cited as predictors of diversion and anecdotal reports from medical providers and law 
enforcement suggest that diversion is more prominent among White, middle class communities [65]. 
However, current research evidence is insufficient to conclude whether these characteristics describe all 
individuals involved in prescription drug diversion or only those who acquire the drugs illicitly. 
Therefore, this study analyzes correlates of membership in three distinct diverter groups in these areas: 1) 
individuals who illicitly acquire prescription drugs, 2) individuals who redistribute them, and 3) 
individuals who engage in both behaviors. We analyze a number of variables that have been identified 
as potentially important correlates of diversion behaviors [23,66] across these groups, including 
demographics, background characteristics, and perceptions of legal risk associated with drug diversion. 
We present data from a cross-sectional Internet study of prescription drug use and diversion patterns in 
three metropolitan areas with high prevalence rates of prescription drug diversion [5,22,29] in the 
eastern United States: New York City, South Florida, and Washington, D.C. 
2. Methods 
2.1. Participants 
The sample consisted of 846 participants (248 males; average age = 36 years) drawn from the 
metropolitan areas of New York City (n = 348), South Florida (n = 202), and Washington, 
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D.C. (n = 319). These cities were targeted for analysis because of previous documentation of 
prescription drug diversion in these metropolitan areas [5,22,29].  
2.2. Procedure 
The present study utilized online surveys to collect data from participants. All participants for this 
study were recruited through cost-free advertisement campaigns on Craigslist.org from May 2013 to 
April 2014. Craigslist is a publicly accessible, online bulletin board where users can post advertisements 
for real estate, employment, sexual encounters, volunteering, and other goods and services. It is a highly 
trafficked site, currently ranked 9th in the United States [67]. Past studies of drug use have successfully 
recruited participants for online research through this site [68–71].  
The present study used elements of time-space sampling for its Craigslist advertisements [72]. A 
member of the research team posted an advertisement in the “volunteers” section of Craigslist at 
randomly selected hours. A true random number service (www.random.org) was used to randomly select 
the hour in which a daily post occurred. Recruitment occurred once per day from 7:00am to 12:00am. A 
total of 325 advertisements were posted during the recruitment period. Advertisements instructed 
interested persons to click on an embedded link to an online survey. These procedures are similar to 
those used in past studies [68,73]. As in these other studies, the respondent sample may have been 
biased because the participants self selected. 
Individuals who clicked on the survey link in the Craigslist advertisements were taken directly to 
the survey information and consent page, which included a description of study procedures and 
risks/benefits of participation. Participants were asked on the consent page to verify that they are at least 
18 years of age. Once age was verified, participants were asked if they agree to participate in the study. 
Those who clicked “YES, I agree to participate” to the participation question were considered to have 
provided consent to participate and were advanced to the next screen, which started the survey. Only 
individuals who consented were eligible to participate. Those who consented to participate and 
completed the survey were given the option to provide an email address for entry into a drawing for one 
of five $100 Amazon gift cards. 
To reduce the potential for multiple survey submissions by a single individual, the Internet Provider 
(IP) addresses of the participants were recorded through the survey host (Qualtrics). Although IP 
addresses do not specifically identify individuals, they are still considered a source of identifying 
information because they can be traced back to a computer with potentially one owner/user [69,74–76]. 
To preserve confidentiality, all IP addresses were destroyed after checking for duplicate submissions. 
We identified 21 duplicate submissions, which were removed from data analyses. The first entry was 
retained as evidenced by an earlier timestamp associated with the IP address. Participant data were also 
removed from analyses because of extensive missing data (i.e., no more than 4 initial questions 
answered, n = 32) or because they failed to meet the study inclusion criteria by obtaining the link to the 
survey from sources other than Craigslist (n = 16) or by residing outside of the targeted geographical 
areas (n = 33). The study protocol received Institutional Review Board approval through the National 
Development and Research Institutes. 
2.3. Measures 
2.3.1. Demographics and background characteristics  
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Demographics and background characteristics were collected for all participants. Seventy one 
percent of the sample identified as female. On average participants were 36 years of age [range 18 to 82 
years]. Participants were asked to identify their race/ethnicity from the following list of categories: 
White/Caucasian (65%), African American/Black (13%), Hispanic/Latino (12%), Asian/Hawaiian/Pacific 
Islander (5%), American Indian/Alaskan Native (1%), more than one race (3%), and other (1%). 
Because 65% of the participants identified as White/Caucasian and no other group was overwhelmingly 
represented, participants were assigned to one of two groups: White (65%) and Non-White (35%). 
Participants were asked to report their annual income by choosing from one of nine categories: less than 
$10,000 (26%), $10,000 to $20,000 (15%), $20,001 to $30,000 (12%), $30,001 to $50,000 (17%), 
$50,001 to $70,000 (10%), $70,001 to $100,000 (14%), $100,001 to $150,000 (6%), $150,001 to 
$200,000 (1%), and more than $200,000 (1%). Because several income categories were too small to 
analyze, and to maximize analytical power, income categories were collapsed into three categories: 
below $30,000 (53%), $30,001 to $70,000 (26%), and above $70,000 (21%). Participants were asked to 
select their highest attained level of education from the following five categories: less than a high school 
degree (3%), high school/GED (14%), some college (37%), college degree (32%), and 
graduate/professional degree (15%). To maximize analytical power, education categories were collapsed 
into two: high school or below (16%) and some college and above (83%). Participants also reported if 
they currently have prescription drug insurance coverage (85%) and whether they had a licit prescription 
for opioids, stimulants, sedatives and tranquilizers (including anti-depressants), and sexual 
enhancement/erectile dysfunction drugs for a legitimated medical purpose within the past year (64%). 
Participants also reported sources of illicitly-obtained drugs. Thirteen percent were obtained from 
medical sources, 32% were given by friends/family, 27% were purchased from friends/family, 15% 
were purchased from a dealer, 4% were stolen from friends/family, 4% were obtained online, and 4% 
were obtained from other sources. Participants reported that 47% of the redistributed prescription drugs 
were given away, 28% were traded, and 25% were sold. 
2.3.2. Illicit prescription drug diversion behaviors  
Participants were asked about their illicit prescription diversion behavior over the last 12 months 
for four drug classes: opioids, stimulants, sedatives and tranquilizers (including anti-depressants), and 
sexual enhancement/erectile dysfunction drugs. Across all analyses, these four drug classes were 
collapsed into a single prescription drug category for analysis. Questions assessed whether participants 
acquired prescription drugs through various medical channels (e.g., doctor shopping, fabricated medical 
problem) or non-medical channels (e.g., family member, friend, drug dealer, online retailer) or 
redistributed any prescription drugs. Participants were classified into four mutually exclusive groups: 1) 
non-diverters (n = 521) representing individuals who did not report any involvement in illicitly acquiring 
or redistributing prescription drugs, 2) illicit acquirers (n = 145) representing individuals who reported 
illicitly acquiring prescription drugs, 3) illicit redistributors (n = 62) representing individuals who 
reported illicitly redistributing prescription drugs, and 4) those who were both illicit acquirers and 
redistributors (n = 118) representing individuals who reported both acquiring and redistributing 
prescription drugs illicitly.  
2.3.3. Perceptions of legal risks of prescription drug diversion  
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Participants were asked a series of items to elicit their perceptions of the legal consequences that 
people risk if they: (1) buy, sell, trade, or give away their prescription drugs; (2) buy, sell, trade, or give 
away prescription drugs that are not their own; (3) approach a doctor for prescription drugs for 
nonmedical use; (4) order prescription drugs not prescribed to them over the Internet; (5) smuggle 
prescription drugs from abroad; and (6) forge doctor prescriptions or call-in false prescriptions. 
Response options included no risk, slight risk, moderate risk, and great risk. Higher scores represented 
greater perceived risk of legal consequences. These items were averaged (i.e., for every participant 
his/her responses to each of the items were summed and divided by six, the number of items of the scale) 
to create an index score for perceived risks of prescription drug diversion (a = .87). The index score 
represents the average rating of risk that the participants attributed to engaging in diversion of 
prescription drugs. Because no gold standard assessment exists for measuring risk associated with 
diversion, the authors created this scale for the purposes of this study. Past research studying risk 
perceptions associated with drugs have generated similar instruments to answer their unique research 
questions [77–79].  
2.3.4. Perceptions of legal risks of illicit drug diversion  
Two questions were asked to elicit participants’ perceptions of the legal consequences that people 
risk if they: (1) buy, sell, trade, or give away marijuana and (2) buy, sell, trade, or give away other 
narcotics (e.g., cocaine, methamphetamine, heroin, etc.). These illicit drugs make up the highest 
percentage of the illicit drug market in the United States [80,81]. Response options included no risk, 
slight risk, moderate risk, and great risk. Higher scores represented greater perceived risk of legal 
consequences. These items were averaged (i.e., for every participant his/her responses to each of the 
items were summed and divided by two, the number of items of the scale) to create an index score for 
perceived risks of illicit drug diversion (a = .70). Similar to the assessment of risk perceptions associated 
with diversion of prescription drugs, the authors created this scale for the purposes of this study. 
2.4. Data analysis 
To minimize the impact of missing data on the analyses, multiple imputations were conducted 
using SPSS [82–84]. This approach utilizes available data to impute missing values and is the preferred 
technique for handling missing data that minimizes bias. Multiple imputation is the preferred method for 
handling missing data which relies on participant’s own observed values and random noise to generate 
missing values. This approach maintains the joint distribution between variables (e.g., variance, 
correlations) and minimizes the bias in estimates of missing values [83,84]. No variable was missing 
more than 25% of data. As is standard with SPSS [82], there were four imputed datasets generated for 
missing values and the fifth one pooled these data together. Predictors with missing data were imputed 
based on other predictors or demographics in the dataset (age, area of residence, gender, race/ethnicity, 
education level, student status, annual income, prescription drug insurance coverage, receipt of a 
prescription in the last year, legal risk of prescription drug diversion, and legal risk of illegal drug 
diversion). Dependent variables were not imputed. Group differences between participants’ diversion 
classification (i.e., non-diverter, illicit acquirer, illicit redistributor, and both illicit acquirer/redistributor) 
and demographic characteristics and risk perception variables were assessed with Chi-Square tests and 
Analyses of Variance (ANOVAs), followed up with planned linear contrasts. Linear contrasts first 
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compared those not involved in illicit behavior to all three diverter groups, then compared the illicit 
acquirers/redistributors to the other two diverter groups and finally compared the illicit acquirer to the 
redistributor groups. Subsequently, multivariate logistic regressions were conducted to assess which 
demographic and risk perception variables remain correlated with illicit acquisition and redistribution 
(by participant diversion classification) when other correlates were controlled.  
3. Results 
3.1. Demographic and Background Characteristics 
Table 1 shows the demographic and background characteristics for the sample. Assignment to 
diversion categories was associated with all of the predictors except for gender and education level (see Table 1). It 
was also associated with self-reported consumption of illicitly acquired prescription drugs. Of note, a 
higher percentage of participants in the illicit acquirer/redistributor group compared to the other groups 
were White, currently a student, had an income above $70,000 per year, did not have prescription drug 
insurance coverage but had a licit prescription for any class of drugs assessed in this study in the past 
year. This group was also younger than any other group with a mean age of 28.38 years. Furthermore, 
those in the illicit acquirer/redistributor group reported the lowest perceived legal risk associated with 
both prescription drug and illegal drug diversion. Additionally, when comparing only the three diverter 
groups on these demographics and background characteristics, the differences remained significant 
(Supplemental Table 1). Results from linear contrasts comparing mean differences in age and perceived 
legal risk of diversion in the four groups are presented in Supplemental Table 2. 
3.2. Illicit Acquirer 
Table 2 shows results from three separate regression analyses (one for each diversion 
classification group). For the acquirer group, age was negatively associated with illicit 
acquisition (β = -0.02, OR = 0.98, p < 0.05). Also, having a history of having a licit 
prescription for any class of drug assessed in this study was positively associated with 
illicit acquisition (β = 1.14, OR = 3.24, p < 0.001). Area of residence, race, gender, education, being a 
student, income, prescription insurance coverage, perceived legal risk of prescription diversion, and 
perceptions of legal risk of illicit drug diversion were not associated with membership in the illicit 
acquirer group.  
3.3. Illicit Redistributor 
For the redistributor group, regression analyses demonstrated that age was negatively associated 
with illicit redistribution (β = -0.04, OR = 0.97, p < 0.01). As with illicit acquisition, a history of having 
a licit prescription for any class of drug assessed in this study was positively associated with illicit 
redistribution (β = 0.89, OR = 2.44, p < 0.05). Additionally, perceived legal risks of prescription 
diversion was negatively associated with redistribution (β = -0.87, OR = 0.42, p < 0.01). Area of 
residence, race, gender, education, being a student, income, insurance coverage, and perceptions of legal 
risk of illicit drug diversion were not associated with membership in the illicit redistributor group.  
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Table 1. Demographics and background characteristics across groups of participants defined by their involvement in diversion 
 Overall 
Sample 
N = 846 (%) 
Not Involved in 
illicit behavior  
n = 521 (%) 
Illicit Acquirer 
n = 145 (%) 
Illicit Redistributor 
n = 62 (%) 
Illicit 
Acquirer/redistributor 
n = 118 (%) 
χ2(df) 
Area of residence 
New York City 
South Florida 
Washington, D.C. 
 
335 (39.7) 
197 (23.3) 
312 (37.0) 
 
182 (35.0) 
131 (24.1) 
207 (39.8) 
 
54 (37.2) 
35 (24.1) 
56 (38.6) 
 
20 (32.7) 
21 (34.4) 
20 (32.7) 
 
79 (66.9) 
10 (8.5) 
29 (24.5) 
47.5 (6)*** 
Gender 
Male  
Female 
 
248 (29.4) 
354 (70.6) 
 
166 (31.9) 
354 (68.1) 
 
43 (29.7) 
102 (70.3) 
 
14 (22.6) 
48 (77.4) 
 
25 (21.6) 
91 (78.4) 
 
6.4 (3)† 
Race/ethnicity 
Non-White 
White 
 
293 (34.8) 
549 (65.2) 
 
192 (36.9) 
328 (63.1) 
 
60 (41.7) 
84 (58.3) 
 
17 (27.4) 
45 (72.6) 
 
24 (20.7) 
92 (79.3) 
 
15.7 (3)*** 
Education level 
H.S. or below 
Some college + 
 
140 (16.6) 
703 (83.4) 
 
89 (17.1) 
431 (82.9) 
 
27 (18.9) 
116 (81.1) 
 
10 (16.1) 
52 (83.9) 
 
14 (11.9) 
104 (88.1) 
 
2.6 (3)  
Student status 
Student 
Not a student 
 
249 (29.9) 
585 (70.1) 
 
125 (24.2) 
392 (75.8) 
 
40 (28.8) 
99 (71.2) 
 
13 (21.0) 
49 (79.0) 
 
71 (61.2) 
45 (38.8) 
 
64.8 (3)*** 
Annual income 
< 30,000 
30,000 to 70,000 
> 70,000 
 
442 (52.7) 
222 (26.5) 
174 (20.8) 
 
281 (54.5) 
150 (29.1) 
85 (16.5) 
 
85 (59.0) 
40 (27.8) 
19 (13.2) 
 
32 (53.3) 
13 (21.7) 
15 (25.0) 
 
44 (37.3) 
19 (16.1) 
55 (46.6) 
 
60.4 (6)*** 
Rx insurance coverage 
Yes 
No 
 
599 (85.1) 
105 (14.9) 
 
390 (92.9) 
30 (7.1) 
 
107 (84.9) 
19 (15.1) 
 
47 (95.9) 
2 (4.1) 
 
55 (50.5) 
54 (49.5) 
127.5 (3) *** 
Rx in last year 
No 
Yes  
 
283 (36.1) 
501 (63.9) 
 
226 (47.2) 
253 (52.8) 
 
33 (24.3) 
103 (75.7) 
 
13 (24.1) 
41 (75.9) 
 
11 (9.6) 
104 (90.4) 
72.5 (3) *** 
 M (SD) F (df1, df2) 
Age 36.16 (14.8) 38.58 (15.6)
a 34.30 (13.3)b 35.03 (13.6)b 28.38 (9.1)b 29.6 (3,211)*** 
Legal risk of Rx drug 
diversion 
3.19 (0.7) 3.37 (0.6)a 3.22 (0.8)b 3.04 (0.6)b 2.667 (0.6)b 39.6 (3,171.9)*** 
Legal risk of illegal 
drug diversion  
3.20 (0.8) 3.38 (0.7)a 3.12 (0.9)b 3.21 (0.7)b 2.67 (0.6)b 34.6 (3,171.9)*** 
Note: χ2 and ANOVA analyses compared the demographic characteristics and perceptions of legal risk of drug diversion across the four 
groups (not involved, acquirer, redistributor, and acquirer/redistributor); Welch ANOVA results are presented to correct for heterogeneity 
of variance; † p < 0.10; * p < 0.05; ** p <.0 001; *** p < 0.001; All planned linear contrasts comparing group differences in age, and risk 
were significant at the p< 0.000 level. Superscripts indicate mean differences = same superscripts indicate no significant difference.
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Supplemental Table 1. Demographics and background characteristics associations across three groups of participants involved in diversion 
 Sample of 
Diverters 
N = 325 (%) 
Illicit Acquirer 
n = 145 (%) 
Illicit Redistributor 
n = 62 (%) 
Illicit Acquirer/redistributor 
n = 118 (%) 
χ2(df) 
Area of residence 
New York City 
South Florida 
Washington, D.C. 
 
153 (47.2) 
66 (20.4) 
105 (32.4) 
 
54 (37.2) 
35 (24.1) 
56 (38.6) 
 
20 (32.7) 
21 (34.4) 
20 (32.7) 
 
79 (66.9) 
10 (8.5) 
29 (24.5) 
34.56 (6)*** 
Gender 
Male 
Female 
 
82 (25.4) 
241 (74.6) 
 
43 (29.7) 
102 (70.3) 
 
14 (22.6) 
48 (77.4) 
 
25 (21.6) 
91 (78.4) 
 
2.5 (2) 
Race/ethnicity 
Non-White 
White 
 
101 (31.4) 
221 (68.6) 
 
60 (41.7) 
84 (58.3) 
 
17 (27.4) 
45 (72.6) 
 
24 (20.7) 
92 (79.3) 
 
13.7 (2)** 
Education level 
H.S. or below 
Some college + 
 
51 (15.8) 
272 (84.2) 
 
27 (18.9) 
116 (81.1) 
 
10 (16.1) 
52 (83.9) 
 
14 (11.9) 
104 (88.1) 
 
2.4 (2) 
Student status 
Student 
Not a student 
 
124 (39.1) 
193 (60.9) 
 
40 (28.8) 
99 (71.2) 
 
13 (21.0) 
49 (79.0) 
 
71 (61.2) 
45 (38.8) 
 
38.5 (2)*** 
Annual income 
< 30,000 
30,000 to 70,000 
> 70,000 
 
161 (50.0) 
72 (22.4) 
89 (27.6) 
 
85 (59.0) 
40 (27.8) 
19 (13.2) 
 
32 (53.3) 
13 (21.7) 
15 (25.0) 
 
44 (37.3) 
19 (16.1) 
55 (46.6) 
 
36.7 (4)*** 
Rx insurance coverage 
Yes 
No 
 
209 (64.3) 
116 (35.7) 
 
107 (84.9) 
19 (15.1) 
 
47 (95.9) 
2 (4.1) 
 
55 (50.5) 
54 (49.5) 
25.4 (2) *** 
Rx in last year 
No 
Yes 
 
209 (73.6) 
75 (26.4) 
 
33 (24.3) 
103 (75.7) 
 
13 (24.1) 
41 (75.9) 
 
11 (9.6) 
104 (90.4) 
50.9 (2) *** 
   M (SD)  F (df1, df2) 
Age 32.3 (12.3) 34.30 (13.3)c
 35.03 (13.6)c 28.38 (9.1)b 12.03 (2,153)*** 
Legal risk of Rx drug 
diversion 
2.9 (0.7) 3.22 (0.8)c 3.04 (0.6)c 2.667 (0.6)b 14.3 (2,168.4)*** 
Legal risk of illegal drug 
diversion 
3.0 (0.8) 3.12 (0.9)c 3.21 (0.7)c 2.67 (0.6)b 20 (2,178.7)*** 
Note: χ2 and ANOVA analyses compared the demographic characteristics and perceptions of legal risk of drug diversion across the four 
groups (not involved, acquirer, redistributor, and acquirer/redistributor); Welch ANOVA results are presented to correct for heterogeneity 
of variance; † p < 0.10; * p < 0.05; ** p < 0.001; *** p < 0.001; All planned linear contrasts comparing group differences in age, and risk 
were significant at the p< 0 .000 level. Superscripts indicate mean differences = same superscripts indicate no significant difference. 
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Table 2. Multivariate logistic regressions predicting involvement in prescription drug diversion relative to non-diverters 
 Acquirer 
B                 SE B       OR (95CI) 
Redistributor 
B              SE B          OR (95CI) 
Acquirer/Redistributor 
B                       SE B                  OR (95CI) 
Area of residence (NYC 
reference) 
South Florida 
Washington, D.C. 
-0.07 
-0.09 
0.27 
0.23 
0.93 (0.53, 1.58) 
0.91 (0.58, 1.44) 
0.60† 
-0.26 
0.36 
0.35 
1.83 (0.90, 3.73) 
0.78 (0.39, 1.53) 
-0.91* 
-0.48 
0.43 
0.31 
0.40 (0.17,0 .93) 
0.62 (0.34, 1.14) 
White -0.13 0.22 0.88 (0.58, 1.34) 0.42 0.34 1.53 (0.79, 2.90) 0.48 0.33 1.62 (0.85, 3.09) 
Female -0.06 0.22 0.94 (0.61, 1.46) 0.33 0.34 1.39 (0.72, 2.70) -0.17 0.32 0.84 (0.45, 1.58) 
Age -0.02* 0.01 0.98 (0.96 , 1.0) -0.04** 0.02 0.97 (0.94, .99) -0.05*** 0.01 0.95 (0.92, 0.98) 
 > High school -0.09 0.28 0.91 (0.53, 1.56) -0.06 0.41 0.95 (0.41, 2.13) -0.58 0.40 0.56 (0.26, 1.23) 
Student status -0.04 0.27 0.96 (0.57, 1.63) -0.33 0.39 0.72 (0.34, 1.54) 0.39 0.34 1.48 (0.75, 2.90) 
Annual income  
(< 30,000, reference) 
30,000 to 70,000 
> 70,000 
-0.04 
-0.18 
0.24 
0.33 
0.96 (0.60, 1.44) 
0.83 (0.44, 1.60) 
-0.31 
.073† 
0.37 
0.42 
0.74 (0.36, 1.52) 
2.07 (0.90, 4.74) 
0.03 
0.71† 
0.36 
0.40 
1.03 (0.51, 2.08) 
2.02 (0.93, 4.12) 
Rx insurance coverage -0.43 0.37 0.65 (0.31, 1.37) 0.17 0.65 1.19 (.30, 4.28) -0.97* 0.41 0.38 (0.17, 0.85) 
Rx in last year 1.14*** 0.23 3.24 (2.00, 4.94) 0.89* 0.35 2.44 (1.22, 4.87) 1.86*** 0.36 6.44 (3.16, 
13.12) 
Legal risk of Rx diversion - 0.40† 0.20 0.67 (0.45, 1.00) -0.87** 0.28 0.42 (-0.24, 0.72) -0.71* 0.29 0.49 (0.28, 0.86) 
Legal risk of illicit drug 
diversion  
- 0.21 0.20 0.81 (0.54, 1.21) 0.17 0.28 1.18(0.69, 2.03) -0.38 0.25 0.69 (0.42, 1.11) 
Note: Results are based on the pooled imputed data; † p < 0.10; * p < 0.05; ** p < 0.0001; *** p < 0.001 
Supplemental table 2. Results from planned linear contrasts comparing means age, perceptions of legal risk associated with 
diversion of prescription and illicit drugs 
 Age Legal risk of Rx drug diversion Legal risk of illegal drug diversion 
 t (df) 
Contrast 1:  
Not involved in illicit trade compared to everyone else 
 
5.7 (425.3)*** 
 
7.9(440.7)*** 
 
6.7(530.1)*** 
Contrast 2:  
Illicit acquirer/redistributor compared to illicit acquirer 
and illicit redistributor 
 
-4.8 (218.9)*** 
 
-5.3(245.3)*** 
 
-6.3(238.2)*** 
Contrast 3:  
Illicit acquirer compared to illicit redistributor 
 
-0.36 (112.8) 
 
-0.13(135.2) 
 
-0.95(154.0) 
Note: Results are based on the pooled imputed data; *** p < 0.001 
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3.4. Illicit Acquirer/Redistributor 
Regression analyses demonstrated several main effects for individuals involved in both illicit acquisition and 
redistribution. As with the illicit acquisition and redistribution groups, age was negatively associated with both 
illicit behaviors (i.e., acquisition and redistribution) (β = - 0.05, OR = 0 .95, p < 0.001) and a history of 
having a licit prescription for any class of drug assessed in this study was positively associated with both 
illicit behaviors (β = 1.86, OR = 6.44, p < 0.001). However, there were some differences with the 
combined group. First, compared to participants in New York City (referent), participants in South 
Florida were less likely to participate in both illicit acquisition and redistribution of prescription 
drugs (β = - 0.91, OR = 0.40, p < 0.05). Second, perceived legal risks of prescription drug 
diversion was negatively associated with being in the combined illicit acquisition and 
redistribution group (β = - 0.71, OR = 0.49, p < 0.05). In fact, those who engaged in both illicit 
acquisition and redistribution had the lowest perception of legal risk associated with prescription and 
illegal drug diversion of all the groups assessed (see Table 1). Finally, participants who had insurance 
with prescription drug coverage were less likely to engage in both acquisition and redistribution than 
those without such coverage (β = - 0.97, OR = 0.38, p < 0.05). Race, gender, education, being a student, 
income, and perceptions of legal risk of illicit drug diversion were not associated with membership in 
the illicit acquirer/redistributor group. 
4. Discussion 
The present study assessed predictors of illicit prescription drug acquisition and redistribution using 
an Internet sample of individuals residing in three metropolitan areas in the United States. Relative to 
those not involved in diversion activities, illicit acquirers and illicit redistributors were more likely to be 
younger and have a licit prescription in the past year. Also, illicit redistributors perceived less risk 
associated with prescription drug diversion. These predictors were also significant for those engaged in 
both illicit activities (acquisition and redistribution). Individuals engaging in both activities were also 
more likely to live in New York City and not have insurance with prescription drug coverage. 
Additionally, while our results support previous research findings on illicit prescription drug behaviors 
being more prevalent among those who are young and White [56–59], our findings show other 
variables—largely unexplored in the literature—to be more significant in their positive association to 
the illicit acquisition and redistribution of prescription drugs. 
Our findings add to the literature on the association between diversion behaviors and income, 
prescription drug insurance coverage, and having a licit prescription. These topics have received little 
attention in past research [23]. This study corroborated that having a prescription, and simultaneous lack 
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of prescription drug coverage, were more important in explaining engagement in both illicit acquisition 
and redistribution than income. These findings may suggest that individuals without prescription drug 
coverage are more likely to engage in the illicit trade of prescription drugs. The negative consequences 
associated with diversion of prescription drugs [9,37–39] generated calls for stricter prescription drug 
policies that would reduce the availability of certain medications such as prescription opioids. The 
present study suggests that, in addition to prescription practices, policy makers should consider 
prescription drug insurance coverage as a variable when examining prescription drug diversion and 
prevention. Arguably, when uninsured, individuals may resort to alternative (illicit) ways of acquiring 
prescription drugs, whether out of “medical need” or not. This is a largely unexplored theme, and more 
research is needed to understand the extent of this phenomenon. Nonetheless, it would be interesting to 
examine how participation in illicit redistribution and acquisition is impacted by the Affordable Care 
Act in the United States, which has enabled more Americans to obtain healthcare coverage but has not 
necessarily translated into prescription drug coverage.  
The study’s findings suggest that there are differences in the characteristics of individuals who 
acquire prescription drugs illicitly as compared to those who redistribute them and those who engage in 
both of these activities. As in previous literature on individuals involved in the illicit drug trade [63,64], 
predictors such as younger age and having legal access to prescription drugs in the past year describe all 
individuals involved in diversion behaviors in the study. Notably, those who redistribute prescription 
drugs perceive themselves to be less at risk of legal consequences related to their actions. As described 
in other literature [66], this may support the notion that lower perceptions of legal consequences may 
contribute to the acceptance of diversion and drug use behaviors. Although causal conclusions cannot be 
drawn from this correlational study, from a prevention perspective, educating the public about the 
illegality of drug diversion should be considered in future studies as a possible diversion deterrent. 
Future studies could also help further examine the motivations behind illicit acquisition and 
redistribution. Qualitative research of individuals who are involved in prescription drug diversion could 
help better understand such motivations [54] and lead to targeted interventions that could help 
discourage diversion [23]. 
The present findings partially replicate past research on the association of demographic variables 
with diversion. For instance, the rates of illicit acquisition and redistribution in our sample with 22% 
reporting acquiring and 31% reporting redistributing were comparable to those of previous studies [23]. 
Furthermore, in this sample ranging in age from 18–82, the younger the participant was, the more likely 
they were to acquire and redistribute prescription drugs illicitly [24,50,85]. Recent evidence suggests 
that younger individuals (adolescents and young adults) calculate risk differently from older individuals 
[86], and future research should consider how the development of risk-taking perceptions and behaviors 
contributes to diversion. These findings also highlight the importance of targeting prevention and 
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intervention strategies towards younger adults. In particular, because this study was conducted with 
Internet users, online and social media forums may be relevant platforms to reach younger individuals. 
In our examinations of group differences, White individuals were more likely to engage in illicit 
redistribution or both acquisition and redistribution but not solely acquisition of prescription drugs. 
These race/ethnicity differences were reported in some previous studies [56] but not others [60,62]. It is 
important to note, however, that although groups differed by race/ethnicity, this variable was not a 
significant predictor of membership in diversion categories in multivariate analyses. This suggests that 
other variables may be more important factors to examine when studying diversion behaviors. We also 
did not find that diversion behaviors differed by gender, although some past studies have found such 
differences [39,58,87,88]. For example, gender differences were observed in one study of in-person 
surveys conducted in public spaces [58]. It is likely that the discrepant findings are driven by the 
different methods used across studies, and are limited in this study in part because the sample was 
primarily female and gender was therefore not equally represented across diversion groups. The online 
survey method utilized in the present study may have contributed to reduced social desirability bias and 
may have elicited more honest responses than in-person interviews across a range of participants [89,90].  
An examination of group differences among diverter groups suggests furthermore that individuals 
engaging in both illicit acquisition and redistribution are more likely to reside in the New York City 
metropolitan area, be younger, be White, be students, be wealthier, and have licit prescriptions but no 
insurance coverage. They are also less likely to associate negative consequences with engaging in the 
illicit trade of prescription drugs. Although not all of these variables significantly predicted membership 
in the acquirer/diverter group in multivariate analyses, suggesting that differences in diversion behaviors 
may be driven by fewer variables, examination of diverter groups suggests that the acquirer/diverter 
group may have a unique profile as compared to other groups. Some of the characteristics of this profile, 
such as student status and being White, overlap with characteristics of individuals who are likely to 
engage in the trade of stimulant prescription drugs [54]. This could be a reflection of increasing 
prescription drug use and availability, for example, with stimulants in collegiate populations, as 
documented by other researchers [2,4,27,33,46–48]. However, the present findings are based on a 
sample of individuals who divert a range of prescription drugs and not solely stimulants. Overall, the 
findings suggest that individuals who engage in both acquisition and redistribution may be different 
from non-diverters and those who acquire or redistribute illicitly. This group that engages in both 
diversion behaviors should be examined more thoroughly in future studies. 
There are some limitations to the present study. The online recruitment of participants may have 
yielded a sample of individuals that does not fully represent the general population or the general 
substance abusing population in the United States [91]. Many demographic characteristics of the present 
sample do, however, corroborate extant research. For example, drug use tends to peak at an earlier age, 
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and the population of drug users is more male dominated. Previous research also suggests that 
individuals with regular access to the Internet tend to be younger, White adults of higher socioeconomic 
status [92,93]. Furthermore, recent evidence suggests that the demographics of Internet users in the  
United States have become more representative of the general population [94,95]. We are unaware of 
any research that specifically examines demographics of Craigslist users across U.S. metropolitan areas. 
Additionally, it is possible that those who engaged in both illicit acquisition and redistribution were 
more likely to take our survey because of self-selection in responding to an online research solicitation 
for a topic of personal relevance. Despite this possibility, the sub-sample of illicit redistributors was 
relatively small, limiting the strength of findings both within this group and across the sample. Future 
studies might find more effective strategies for Internet-based recruitment to garner a wider and more 
representative sample through the use of other websites or online platforms.  
Another limitation of this study is that legal perceptions of prescription diversion risk were conceptualized 
as a singular category. In other words, legal risks associated with different behaviors (i.e., buying, selling, 
trading, or giving away of prescription drugs) were not parsed out. Future studies could improve upon 
the content validity regarding this line of inquiry by asking about these diversion practices separately. 
Furthermore, subsequent diversion research that aims to better understand the perceived risks of these 
various practices should inform the design of more nuanced interventions.  
A particular strength of the present study is the use of the online survey approach to data collection, 
which may have minimized social desirability bias and has been shown to be useful in recruiting high 
risk samples. Online surveys are an efficient, cost-effective, and increasingly common research 
method [96] and are particularly useful for collecting data from high risk or stigmatized populations 
(e.g., drug users, sexual minorities) [89,97–101]. Some research also suggests that response rates of 
online surveys may be comparable to or higher than those for traditional survey methods such as phone 
or mail [100,102,103]. Furthermore, this type of research removes potential interviewer effects (i.e., 
social desirability) that can occur when attempting to collect data on sensitive topics during 
interviews [89,90]. Indeed, at least one study corroborated the validity of this method, which noted a 
higher reporting of substance use behaviors via a web-based survey compared to phone or mail [104]. 
Another strength of our study is that much of the previous research on prescription drug diversion 
has focused on specific groups (e.g., college students, pain patients) or specific drugs (e.g., opioids, 
stimulants). By not limiting our study to a specific population or drug class, our study was able to 
conduct analyses across demographic groups and drug class. These findings are an important addition to 
the literature, as they show that various behaviors under the umbrella of drug diversion may differ across 
the wider population. Our findings also indicate that predictors of drug diversion vary across diversion 
behaviors. While this study does not explore motivations behind different diversion behaviors, future 
research on such motivations would better inform interventions for the prevention or mitigation of risk 
associated with these behaviors. Future research should also examine possible predictors of illicit 
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acquisition and redistribution with respect to different drug classes. Inter-group comparisons of these 
behaviors would also help us better understand the motivators and pathways that drive prescription drug 
diversion in the United States. 
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